Enterococcus species cause increasing numbers of infections in hospitals. They contribute to the increasing mortality rates, mostly in patients with comorbidities, who suffer from severe diseases. Enterococcus resistances against most antibiotics have been described, including novel antibiotics. Therefore, there is an ongoing demand for novel types of antibiotics that may overcome bacterial resistances. We discovered a novel class of antibiotics resulting from a simple one-pot reaction of indole and o-phthaldialdehyde. Differently substituted indolyl benzocarbazoles were yielded. Both the indole substitution and the positioning at the molecular scaffold influence the antibacterial activity towards the various strains of Enterococcus species with the highest relevance to nosocomial infections. Structure-activity relationships are discussed, and the first lead compounds were identified as also being effective in the case of a vancomycin resistance.
肠球菌引起的医院感染越来越多。肠球菌导致死亡率上升,其中大部分是患有严重疾病的合并症患者。肠球菌对大多数抗生素都有耐药性,包括新型抗生素。因此,人们一直需要能克服细菌耐药性的新型抗生素。我们发现了一种新型抗生素,它是由
吲哚和邻
苯甲醛通过简单的一锅反应生成的。我们得到了不同取代的
吲哚基苯并
咔唑。
吲哚的取代和分子支架上的位置都会影响其对各种肠球菌菌株的抗菌活性,而这些菌株与医院内感染的关系最为密切。对结构-活性关系进行了讨论,并确定了第一种先导化合物在
万古霉素耐药的情况下也有效。